Though late to the party compared to other industry mammoths, Abbott joins a pulsed field ablation market poised for ...

Abbott’s trial arrives in the wake of a growing IVL market. Johnson & Johnson has a FDA-approved technology, gaining access ...

The company is first rolling out the use of the Volt system among European Union doctors who have already gained experience ...

Abbott has announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) ...

The Volt PFA system. [Image courtesy of Abbott] Abbott (NYSE: ABT) + announced it received CE mark approval in Europe for its ...

Abbott's Volt™ PFA System is designed to provide a new therapy option for people battling heart rhythm disorders such as ...

Abbott Park, Illinois Saturday, March 29, 2025, 13:00 Hrs [IST] ...

Abbott is joining the worldwide race to make pulsed field ablation the standard procedure for atrial fibrillation with an ...

Investing in stocks comes with risks. There's no way around that fact. However, some stocks can be less risky than others ...

Abbott Laboratories (NYSE: ABT) stock was in fine health on the second-to-last trading day of the week, thanks to news from ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Zacks.com users have recently been watching Abbott (ABT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.